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The diversity of the T cell repertoire specific for foreign antigens has been
evaluated by a number of experimental approaches . To this end, monoclonal T
cell populations have recently been used to probe the fine specificity of the
antigen and la epitopes recognized by T cells, in particular where the overall
antigen molecule encountered by the T cell is a potentially complex foreign
protein . Previous analyses of the antigen fine specificity of cloned T cells have
used variants ofprotein antigens, cleavage fragments derived from intact antigen
molecules, or synthetic peptides made to represent native or variant amino acid
sequences expressed on the antigen molecule (reviewed in references 1 and 2) .
These studies have identified the antigenic peptides recognized on protein
antigens by T cells in several model systems, including the responses of cloned
T cells to cytochrome c (3-5), myoglobin (6-9), lysozyme (10-11), OVA (12,
13), and influenza virus hemagglutinin (14) . In each of the systems in which a
panel ofT cells was studied, it hasappeared that only a small number ofantigenic
epitopes on the overall protein antigen are recognized by T cells (3-13) . More-
over, when the association between antigen specificity and la specificity has been
evaluated, an additional constraint on theT cell repertoire has been recognized
since strong preferential associations appear to exist between the antigenic
epitope recognizedand the self la molecule recognized by theTcell in association
with the antigen .
The reason(s) for this apparently limited antigen plus la fine specificity reper-
toire expressed by T cells is not yet clear . Structural constraints at the level of
antigen processing, presentation, or antigen and la association have been pro-
posed to account for at least some examples ofimmunodominance (15, 16) . The
other major parameter that might be expected to influence apparent immuno-
dominance is the extent of the expressed T cell receptor repertoire . This
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SPECIFICITY OF NUCLEASE-SPECIFIC T CELL CLONES
repertoire matures under influences that include strong effects of the T cell
maturation environment, resulting in both self tolerance and in skewing toward
self MHC restriction. It therefore follows that experimental systems used to
study the diversity of the T cell repertoire for foreign antigens will be influenced
by the effects of self tolerance on that repertoire. Thus, for antigens that are
structurally and antigenically similar to the self proteins of a responding orga-
nism, it is likely that the number of epitopes on that antigen that will be
recognized by T cells will be limited to those that differ from the self proteins to
which physiologic tolerance has been induced. It is notable that the antigens that
have to date been used most extensively to study the fine specificity of the T cell
repertoire are cytochrome c, myoglobin, lysozyme, and OVA. Each of these
antigens differs from the homologues expressed in responding experimental
mice by only a few amino acids. Although this limited species variation has been
exploited in defining antigenic epitopes, it has also left open the possibility that
apparent limitations in the number of immunogenic epitopes recognized by T
cells on complex antigenic molecules reflect the outcome of self tolerance to
most of the determinants on these closely related molecules.
The present studies evaluate the diversity expressed in the T cell repertoire
specific for an antigen that is more distant from mammalian proteins . A series
of T cell clones was generated specific for the antigen staphylococcal nuclease
(Nase),' a bacterially derived protein that is 149 amino acids in length. The use
of a series of overlapping 20-amino-acid synthetic peptides spanning the entire
Nase molecule has allowed the assignment of antigen fine specificities to these
clones and has permitted an analysis of the relationship between the antigenic
determinant recognized by a given T cell and the self MHC product used as a




C57BL/10 (B10), B10.A (5R), B10.A (4R), and (C57BL/6 X A/J)F, mice
were purchased from The Jackson Laboratory, Bar Harbor, ME. [B10.A (5R) X B10.A
(4R)IF, mice were bred in our own colony.
Antigens.
￿
Lysozyme was purchased from Cooper Biomedical, Inc. (Malvern, PA), and
Nase was either purchased (Boehringer Mannheim, Penzberg, Federal Republic of Ger-
many) or prepared in this laboratory. Nase fragments 1-126, 127-149, 6-48, 49-149, and
99-149 were prepared by trypsin digestion and CNBr cleavage of Nase, as previously
described (17).
Nase peptides were synthesized by the solid-phase method (18). The t-butoxycar-
bonyl(Boc)-amino acid coupled to hydroxymethyl-phenyl-acetaminodomethyl(Pam)-poly-
styrene was purchased from Applied Biosystems, Inc. (Foster City, CA). The peptide
assembly at a 0.5 mmol scale was carried out automatically with an Applied Biosystems,
Inc. 430A Peptide Synthesizer, using Boc-amino acids (Peninsula Laboratories, Inc.,
Belmont, CA) to give Boc-Arg (Tos)-Thr (Bzl)Asp-(OBzl)-Lys(CI-Z)-Tyr(Br-Z)-Gly-
Arg(Tos)-Gly-Leu-Ala Ala-Asp(OBz1)-Gly-Lys (Cl-Z)-Met-Val-Asn-OCH2-Pam-resin (Nase
81-100) and Boc-Tyr(Br-Z)-Ile-Tyr (Br-Z)-Ala-Asp(OBzl)-Gly-Lys(CI-Z)-Met-Val-Asn-
Glu(OBzl)-Ala-Leu-Val-Arg (Tos)-Gln-Gly-Leu-Ala-Lys (CI-Z)-OCH2-Pam-resin (Nase 91-
110). After treatment of the peptidyl-resin with anhydrous hydrogen fluoride (10 ml/g
resin) in the presence of p-cresol (1 ml/g resin) and p-thiocresol (1 g/g resin) for 1 h at
0°C (19), the resin was washed with diethyl ether (20 ml X 5) to remove scavengers, and
with 30% glacial acetic acid (20 ml X 5) to solubilize the synthetic peptide . The lyophilized
' Abbreviations used in this paper:
￿






























































peptide recovered in the aqueous phase was desalted on a G-25 column (2.5 X 90 cm) in
1 M glacial acetic acid, and was lyophilized. Aliquots of each peptide were hydrolyzed in
6 M HCl containing 0.2% phenol at 110°C for 24 h, and hydrolysates were analyzed with
a 6300 amino acid analyzer (Beckman Instruments, Inc., Fullerton, CA), and the following
compositions were determined for the synthetic peptide corresponding to Nase (81-100):
Asx 3 .1 (3), Thr 0.8 (1), Gly 3 .2 (3), Ala 2.1 (2), Val 1 .2 (1), lie 1 .0 (1), Leu 1 .1 (1), Tyr
3.1 (3), Lys 2.1 (2), Arg 1 .9 (2); and for the synthetic peptide corresponding to Nase (91-
110): Asx 1 .8 (2), Glx 2.1 (2), Gly 2.0 (2), Ala 3.1 (3), Val 2.0 (2), Met 0.9 (1), lie 0.9 (1),
Leu 2.1 (2), Tyr 1 .8 (2), Lys 2.1 (2), Arg 0.9 (1). The theoretical number of residues
expected in each peptide is shown in parenthesis. Subsequently, an aliquot (0.2 mg) of
each crude peptide mixture was separated on an analytical Vydac C, reverse-phase HPLC
column (0.46 X 25 cm; 5 Im particle size; 300 A pore size) (The Separations Group,
Hesperia, CA) using 0.1 % trifluoroacetic acid (TFA) (Pierce Chemical Co., Rockford, IL)
and a 60 min, linear gradient of 0-60% acetonitrile (J. T. Baker Chemical Co., Phillips-
burg, NJ) containing 0.1% TFA. After optimization of isocratic elution conditions for
each peptide mixture (0 .2 mg) using an analytical Vydac C4 and systems of 0.1% TFA
and acetonitrile containing 0.1 % TFA, semipreparative purification of each peptide was
carried out on a Vydac C4 (2 .2 X 25 cm) (15-20 ;m particle size; 300 A pore size) under
isocratic elution conditions shown to give the maximum chromatographic resolution (20 ;
J. C. Ford and J. A. Smith, manuscript in preparation). The other peptides were
synthesized in a similar fashion. A schematic drawing depicting the overlapping peptides
of the Nase molecule is shown (Fig. 1).
Antisera.
￿
We used the supernatant ascites form of the mAbs 34-5-3 (anti-I-A' cross-
reactive on I-Ad) and 14-4-4 (anti-I-E' crossreactive on H-2d.P.`) (21).
Culture Medium.
￿
The medium used for assays of proliferation and maintenance of T
cell clones was RPMI 1640 supplemented with 100 U/ml penicillin, 100,ug/ml strepto-
mycin, 10 mM Hepes, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 2 mM
L-glutamine, 5 X 10-5 M 2-ME and 10% FCS.
Proliferation.
￿
Cultures were performed in a total volume of 200 Al in flat-bottomed
wells (3040; Falcon Labware, Oxnard, CA) incubated for 3 .5 d at 37° C in 5% C02-
humidified air. T cell proliferation was assayed by culturing 104 T cells with irradiated
(3,300 rad) spleen cells in complete medium containing 10% FCS. We assessed amount900
￿
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TABLE I
Antigen Specificity ofNuclease-specific T Cell Clones
* 10" cloned T cells were cocultured with 4 X 10 5 irradiated (136A)F1
irradiated spleen cells in the presence of 12 jug/ml nuclease, 50 ug/ml
lysozyme, or medium for 3 d .
of [sH]TdR incorporated during a 12 h pulse (1 ACi/well, specific activity 2 Ci/,UM ; New
England Nuclear, Boston, MA) . Results are given as the arithmetic mean CPM oftriplicate
cultures ± SEM .
T Cell Clones.
￿
T cell clones were prepared,as previously described (22) . T cell clones
were derived from lymph node cells from mice primed with 100 Ag of Nase in the
footpads . 4 X 105 nylon-nonadherent T cells were cultured in the presence of 3 X 106
irradiated (3,300 rad) syngeneic spleen cells and antigen . This feeding was repeated every
10-14 d . To remove dead cells from theT cell lines, the cells were layered and centrifuged
over lymphocyte separating medium (Litton Bionetics, Charleston, SC) at the end ofeach
cycle . After 2-4 cycles o£ stimulation the T cell lines were cloned by limiting dilution .
Positive wells were expanded and clones were maintained in the presence of antigen,
syngeneic stimulator cells, and a source of IL-2 if required for growth . All the T cell
clones used in this study were obtained from T cells plated at 1 cell per well or 0 .3 cell
per well with 50 and 20% of wells positive, respectively .
Results
Antigen Specificity and MHC Restriction of Nase-reactive T Cell Clones.
￿
Two
independent anti-Nase lines were generated from B6AF, T cells . From these
two lines, we derived a total of nine anti-Nase clones by limiting dilution . The
antigen specificity of these clones was assessed by determining the proliferative
responsesof each clone to Nase or to controlantigen in the presence of irradiated
syngeneic spleen cells. As shown in the representative experiment presented in
Table I, each of the Nase-specific T cell clones proliferated significantly in the
presence of the specific antigen Nase . In contrast, there was no significant
proliferative response to lysozyme, a protein similar to Nase in overall size and
charge .
The MHC restriction pattern of each Nase-specific T cell clone was next
evaluated by comparing the responses to Nase generated in the presence ofAPC
of different MHC types. APC were derived from B6AF, (H-2b X H-2') or
parental (H-2b or H-2a) strain mice, or from mice expressing recombinant H-2
types . Some Nase-specific clones (G28 and N36) appear to be H-2'-restricted
since they responded to Nase in the presence of irradiated B10 (H-2b), but not
B10.A (H-2 a) spleen cells (Table II) . Other B6AF t clones (e.g ., G60, N24.3, or
N40) were H-2a-restricted, responding to Nase plus B10.A, but not B10 APC .
Intra-H-2 recombinant APC were used to further map these MHC restrictions .
Each of the two H-2'-restricted clones studied responded in the presence of
T cell clones*
Medium
cpm X 10' + SEM
Nuclease Lysozyme
G31 0.33 t 0.05 5.0 ± 0.5 0.43 ± 0.04
G60 0.27 t 0.03 5.0 ± 0.3 0.30 ± 0.02
G56 0.32 ± 0.05 36.4 ± 4.2 0.64 t 0.08
G28 0.50 ± 0.04 16 .4 ± 1 .5 0.64 ± 0.07






H-2Subregion Specificity ofNuclease-specific TCell Clones
* Irradiated spleen cells (4 x 1Os) from various intra-H-2 recombinant strains were incubated with nuclease-specific T cell clone cells
(10*)in the presence of 12 hg/ml of nuclease for 3 d.
TABLE III
Inhibition ofNuclease-specific TCell Clones with Anti-Ia Antibodies
Nuclease:
* 10' T cells from clone G28.4 and N24.3 were incubated from the onset of
culture with 4 X 105 (1310 X B10.A)F, stimulator cells in the presence of
nuclease (12 ug/ml) and anti-Iaantibodies.
BIO.A(5R), but not BIO.A(4R) spleen cells, suggesting that the relevant restrict-
ing element was K- or I-A-encoded. In contrast, each of the seven H-2a-restricted
B6AFI-derived clones was unresponsive to antigen presentation by B10.A(4R)
spleen cells. Six of these seven clones were also unresponsive to B10 .A(5R) cells,
but responded to Nase in the presence of [B10.A(5R) X B10 .A(4R)Fl APC
(Table II and data not shown) . This pattern of genetic complementation sug-
gested that the restriction element recognized by these clones was on the E« Es
product. One H-2a-restricted clone, N40, responded to Nase in association with
B10.A or BIO.A(5R) APC, but not to Nase in association with 1310 or B10.A(4R)
APC, suggesting restriction to a determinant expressed by both E« E' and
E« Es.
The MHC restriction specificity of Nase-specific T cell clones was further
evaluated by examining the effects of anti-la mAbs on T cell proliferative
responses (Table 111). The response of the H-2b-restricted clone G28.4 to (1110
X B10.A)F 1 APC was strongly inhibited by the anti-I-Ab antibody 34-5-3, but
was not inhibited by the anti-I-E' antibody 14-4-4, suggesting that the clone















1310 b b b b b b b b 0.26±0.02 12.310.7 0.20±0.05 0.3±0.01 3.7±0.2
B10.A k k k k k d d d 2.1 ± 0.2 0.35 ± 0.3 7.0 :t 1.7 11.9 ± 0.6 0.4 ±0.1
BIO.A(5R) b b b k k d d d 0.53±0.1 9.4±1.0 0.7±0.03 10.610.7 1.6±0.09
B10.A(4R) k k b b b b b b 0.17±0.5 0.31±0.6 0.4±0.1 0.7±0.09 0.18±0.04
(5Rx4R)F, b b b k k d d d 5.0±0.4 16.4±1 .5 14.6±1.8 16.910.7 2.3±0.1
mAbs Concentra-
tion





- 16.2 ± 0.5 12.9 ± 1.1
Anti-I-Ab 25 1.8 ± 0.3 9.8 ± 0.4
8 5.5 ± 0.1 10.9 ± 1.5
2 6.9 t 0.6 17.3 t 1.2
Anti-I-Ek 1.2 26.1 ±4.8 2.3 ± 0.4
0.4 29.8 ± 2.2 3.6 ± 0.7
0.1 25.8 ± 3.1 3.6 ± 0.7902
￿








0.3 0 .1 0 .03 0.01
￿






Tcell clone responses to fragmentsof theNase molecule. 10 4 clonedT cells were
incubated with various concentrationsof cyanogen bromidecleavage fragmentsofthenuclease
molecule in the presence of 4 X 105 irradiated spleens. O, 1-149;" , 6-48 ; O, 49-149 ; ", 99-
149; A, 1-126 ; A, 127-149 . The response of T cells in the absence of antigen and in the
presence or absence of irradiated stimulator cells was consistently <10'cpm.
N24.3 was inhibited reciprocally by anti-I-E k, but notanti-I-Ab antibody, indicat-
ing its specificity for Nase in association with Ekk Ek k .
Responses of Nase-specific Clones to Cleavage Fragments of Nase.
￿
The initial
attempts to better define the Nase molecule's antigenic structures that are
recognized by T cells used cyanogen bromide and tryptic fragments of the Nase
molecule, fragments that were previously used to study the responses of hetero-
geneous Nase-specific T cell populations (23, 24) . Cloned T cells were cultured
with syngeneic APC and titrated molar quantities of intact Nase (1-149) or Nase
fragments . For all clones tested, including H-2b-restricted and H-2a-restricted
clones, we observed responses to the large fragments 1-126 and 49-149, and
these responses were uniformly higher in magnitude than those generated to
intact Nase (Fig . 2) . It is unclear whether the enhanced antigenicity of these
fragments is due to purely immunologic factors, e.g ., the availability of antigenic
determinants for processing and presentation, or relates to the abrogation of
Nase enzymatic activity in the fragments (17) . Fragments 99-149 and 127-149
failed to stimulate any of the Nase-specific clones, and fragment 6-48 gave
responses that were inconsistentandseen only at the highestantigen dose studied .
The results of these studies using Nase cleavage fragments thus failed to reveal
any differences in the antigen specificities of the T cell clones tested . The fact
that only fragments 1-126 or 49-149 were stimulatory suggested either that : (a)
the sequences included in the area of amino acids 49-98 are critical for T cell
recognition (since this sequence is present in each of the stimulatory peptides
but absent from nonstimulatory peptides), or (b) the determinants recognized by
T cells are conformational and require contributions by multiple sequences only
present in the large 1-126 or 49-149 peptides .
Responses of Nase-specific Clones to Synthetic Peptides .
￿
To further pursue the
analysis of cloned T cell fine specificity, a series of synthetic peptides were
analyzed . We synthesized peptides 20 amino acids in length which corresponded





T cell clone responses to 20-amino-acid peptides of theNase molecule . 1 O' cloned
T cells were incubated with various concentrations (0.9-0.03 wM) of nuclease peptides of 20
amino acids in the presence of 4 X 105 irradiated spleen cells. The response ofT cells in the
absence ofantigenand in the presence or absence of irradiated stimulator cells was consistently
<10' cpm .
acids, thus corresponding to Nase amino acid residues 1-20, 11-30, 21-40, . . .
131-149 . Nase-specific T cell clones were assayed for responsiveness to titrated
molar quantities of each of the 14 peptides derived from the Nase amino acid
sequence .
Two independently derived H-26-restricted clones responded strongly to the
synthetic peptide 91-110 over the entire range of peptide concentrations studied,
and the magnitudes of these responses were greater than those generated to the
native Nase molecule (Fig . 3) . These clones were completely unresponsive to the
other peptides tested, with the sole exception of smaller and inconsistent re-904
￿
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FIGURE 4. T cell clone responses to crossreactive Nase peptides. 10' cloned 24.3 T cells
were incubatedwith peptide51-70and 81-100 at concentrations of9-0.01 AM in thepresence
of 4 x 105 irradiated spleen cells to determine the quantitative difference in stimulator
capacity. ", 51-70; O, 81-100. The response of T cells in the absence of antigen and in the
presence or absence of irradiated stimulator cells was consistently <10' cpm.
sponses to single concentrations of the peptide 41-60. Each of three subclones
derived at 0.3 cells per well gave a response pattern identical to that expressed
by the H-2'-restricted clone G28 (data not shown).
The seven H-2a-restricted Nase-specific clones gave response patterns that
were distinct from thoseobserved forH-2b-restricted clones. Each ofthese clones
was completely unresponsive to peptide 91-110, the peptide to which the H-2'-
restricted clones were consistently responsive (Fig. 3). Reciprocally, each ofthe
H-2a (Ea E')-restrictedclones was strongly responsive to peptide 81-100, whereas
the H-2b (A. A#)-restricted clones were completely unresponsive to this overlap-
ping peptide. It was striking that a number ofH-2a-restricted clones responded
to peptide 51-70, in addition to responding to 81-100 and not responding
significantly to other peptides. The monoclonal nature of the T cell lines
responding to these two peptides was supported by the derivation of clones
N24.1, N24.3, and G31 .2, each ofwhichwasgeneratedbyinitial limiting dilution
cloning followed by subcloning at 0.3 cells per well. This pattern of apparent
crossreactivity was observed in clones derived from two independent T cell lines
(lines G and N). The dose-response curve to titrated molar amounts ofpeptides
51-70 and 81-100 indicated that peptide 51-70 was significantly less efficient in
triggering T cell responses in the dual reactive clones, suggesting a range of27-
fold to 300-fold difference in different clones in repeated titrations (Fig. 4).
Recombinant strain APC were then used to determine whether the responses
ofT cell clones to synthetic peptides showed the same MHC restrictions as their
responses to the native Nase molecule (Table IV). Responses of H-2b-restricted
clones G28.4 and N36 to 91-110 were observed in the presence of B10 or
B10.A(5R), but not B10.A or B10.A(4R) spleen cells, paralleling the mappingtoTABLE IV
The Responses of T Cell Clones to Nuclease Peptides Are Under the










* T cell clones were incubated in the presence of whole nuclease 1-149
(0.7 IAM), peptide 81-100 (0.1 WM), or 91-110 (0.1 jM) in the presence
of irradiated spleen cells.
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Kb or I-Ab of responses to intact Nase. Responses of the H-2a-restricted clones to
both 81-100 and 51-70 also showed the same genetic restrictions as the responses
to native Nase, with responses by clones G31 and N24 in the presence of B10A,
but not B10, BIO.A(4R), or BIO.A(5R) APC, and response by clone N40 in the
presence of B10.A or B10.A(5R) APC (data not shown).
A Nase-specific T cell line was also generated from BALB/c spleen cells, and
clones were derived from that line by limiting dilution. One cloned BALB/c T
cell line (C30) and its subcloned derivative (C30.1) were studied for their
reactivity patterns to Nase peptides. In contrast to any of the H-2a-restricted or
H-2b-restricted B6AF1 clones, these BALB/c T cell lines responded to peptide
61-80, and not to other Nase peptides, including 81-100 and 91-110 (data not
shown).
Discussion
In the present study we used cloned T cells and synthetic peptides to analyze
MHC-restricted, antigen-specific T cell recognition of the protein antigen Nase.
We evaluated a total of 10 Nase-specific clones, derived from two independent
B6AF1 lines and one BALB/c line . Each of these T cell clones was shown to be
specific for one peptide component of the overall Nase protein (with the excep-
tion of the crossreactivity described below). Two of the B6AF, clones were A%
As-restricted. Seven were restricted by complementing H-2a genes, which most
probably are those encoding the Ea Ek product, and one of these seven also
crossreactivelyrecognized the BlO.A(5R) (E«E0)productas arestriction element.
Spleen cells
T cell clone proliferation*
Peptide (cpm x 10' ± SEM)
N40 N24.3 N28.4
B10 1-149 0.6±0.09 0.2±0.09 5.9±0.3
81-100 0.8 ± 0.1 0.2 ± 0.02 ND
91-110 ND ND 15.1 ± 0.8
B10.A 1-149 18.9±2.8 7.6±0.1 0.4±0.01
81-100 46.4 ± 4.2 9.5 ± 0.9 ND
91-110 ND ND 0.7 ± 0.08
B10.A(5R) 1-149 6.7 ± 1.5 0.9 ± 0.09 5.1 ± 0.4
81-100 6.6 ± 1.9 0.4 ± 0.05 ND
91-110 ND ND 13.9 ± 0.6
B10.A(4R) 1-149 1.1 ± 0.5 0.1 ± 0.006 0.3 ± 0.1
81-100 0.6±0.1 0.7±0.1 ND
91-110 ND ND 0.7 ± 0.05
(51Z x 4R)F, 1-149 15.0 ± 0.5 5.6 ± 0.2 9.0 ± 1.5
81-100 49.4 ± 3.7 6.8 ± 1.2 ND906
￿
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Moreover, in the panel of T cell clones studied here, the identity of the peptide
recognized by a given Nase-specific T cell correlated with the MHC restriction
pattern of that T cell . Both Aa Ag-restricted clones were highly responsive to
peptide 91-110, and not to the other synthetic Nase peptides ; whereas all of the
E' E,' clones were consistently responsive to peptide 81-100 but not to 91-110
or other Nase peptides . Certain of these Ea EkT cells responded to peptide 51-
70 as well as to 81-100, although the markedly shifted dose-response curve
indicated a reduced efficiency of activation by peptide 51-70.
The finding that Nase-specific T cells are responsive to discrete Nase peptides
is consistent with previous data, indicating that protein antigen-specific T cells
recognize limited peptide determinants (1, 2, 5, 8-11) . The present findings also
suggest that for Nase, as for other antigens, a limited number of peptides may
represent the bulk of immunodominant sites recognized byT cells on a protein
antigen . The reason for this limited repertoire is not clear . The most extensive
previous analyses of this area were carried out with species variants ofcytochrome
c (3-5), myoglobin (6-9), lysozyme (10, 11), and OVA (12, 13) . Since each of
these protein antigens differs by only a few amino acids from the homologue
present in mice (the source of responding T cells), it was possible that self
tolerance contributed significantly to the limitation in the number of immuno-
genic sites recognized on these antigens. That is, self tolerance to determinants
shared by homologous foreign and self proteins may have left only a small
number of unique foreign determinants to be recognized as immunogenic . In
the present studies, the foreign antigen used was Nase, a bacterial product
without extensive sequence homology to known mammalian proteins (C . C. Yue,
NIH ; personal communication) . The fact that in clonal T cell responses to Nase
a limited number of immunodominant peptides are recognized in association
with a given la molecule suggests that self tolerance is not a universally important
component in the limited repertoire of T cells for sites on foreign proteins .
These findings are consistent with the concept that structural properties
intrinsic to peptide molecules may play a critical role in determining immuno-
genicity . Recently, DeLisi and Berzofsky (15) have reported evidence that the
majority of immunodominant epitopes recognized byT lymphocytes are amphi-
pathic structures, i.e ., structures with separated hydrophobic and hydrophilic
domains . Most of these had a periodic variation in hydrophobicity consistent
with the ability to fold into an amphipathic « helix in which hydrophobic residues
are primarily on one side of the helix and hydrophilic ones on the other . The
data so far available for T cell recognition of Nase peptides do not as yet permit
a statistically powerful test of the ability to predict immunodominant epitopes on
the basis of amphipathicity . Nevertheless, all four of the peptides that stimulated
T cell clones in the present study (51-70, 61-80, 81-100, and 91-110) were
compatible with predictions made on the basis of amphipathicity . It is anticipated
that a finer analysis of the epitopes that are recognized on these peptides by T
cells will allow a more powerful test of this hypothesis .
The data presented here suggest that, for a complex protein antigen, different
peptide determinants may be recognized by T cells predominantly in association
with different la-restricting elements : e.g ., peptide 81-100 in association with
E~ Ek and 91-110 in association with Ab Ab . A number of previous studies haveFINNEGAN ET AL.
￿
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similarly indicated that different antigenic determinants on a complex protein
are recognized by Tcells in association with different class 11 molecules. Shastri
et al. (11) showed this finding in a clonal analysis of T cell responses to the
synthetic peptides ofhen egg lysozyme. Lysozyme peptide 81-96 was recognized
in association with I-Ab, whereas peptide 74-86 was recognized in association
with I-A', analogous to the associations described in the present study for Nase
peptides. However, when a more extensive evaluation of antigen specificity was
carried out using substituted lysozyme peptides, it was found that T cells that
superficially expressed the same peptide specificity were in fact quite heteroge-
neous in their antigen fine specificity. We are currently making a similar analysis
ofclonal fine specificity for Nase peptides. Berkower et al. (8) have also used T
cell clones in a panel ofspecies variants ofmyoglobin to evaluate the effect of la
restriction on "epitope dominance," and have similarly observed that T cell
clones specific for one epitope were restricted to I-Ad, whereas clones specific
for a second epitope were restricted to I-Ed. All ofthese findings are consistent
with the earlier studies ofHeber-Katz et al. (3) and Matis et al. (4), which showed
a correlation between the la restriction elementand the fine specificity ofantigen
recognition by T cells, and are in fact consistent with the earliest observations of
MHC-linked immune response gene control.
Although the mechanisms underlying the preferential association of a given
antigen specificity with a given la-restricting element remain unknown, two
alternative models have been proposed. In the first of these models, a given
antigen epitope may be selectively associated, at the level of the APC, with a
given la molecule. Direct evidence supporting the existence of such selective
associations in the binding ofantigen to la molecules hasrecently been presented
by Babbitt et al. (16). It remains to be determined whether this phenomenon
will be widely generalized, and whether it is functionally important in instances
ofselective recognition of antigen plus la by Tcells. The second model is based
upon an hypothesized absence in the T cell repertoire of receptors that can
recognize certain epitope plus la combinations, despite the existence of these
epitope/la complexes in potentially antigenic form (25). A number of mecha-
nisms, either germline- or differentiation-dependent, might underlie such defi-
ciencies in the T cell repertoire. More direct and detailed analyses of specific
interactions between antigenic peptides and la molecules, and ultimately with
the T cell receptor, may help to distinguish among these alternatives.
The finding that several E' E'-restricted T cell clones derived from two
independent lines responded most efficiently to peptide 81-100, and consistently
(although less efficiently) to peptide 51-70 was unexpected. Since these were
independent synthetic peptides, and not fragments prepared from a common
Nase molecule, it is not likely that the reactivity we saw represents a contamina-
tion ofone peptide with another. In addition, since several clones and subclones
displayed this crossreactivity, it is unlikely that it is due to responses of distinct
51-70-reactive and 81-100-reactive cells contained within each T cell line. The
basis for crossreactive recognition bya given T cell ofboth 81-100 and 51-70 in
association with Ea Es is unclear. The amino acid sequences of these peptides do
not reveal extensive homologies. However, it is striking that there are two
tripeptides in common between these sequences, Lys-Tyr-Gly and Lys-Met-Val,908
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and these are spaced almost the same distance apart (8 and 10 residues) in the
two peptides. Moreover, immediately adjacent to the first Lys, 81-100 has an
Asp whereas 51-70 has a Glu. As this substitution is very conservative, the
peptides may share homologous tetrapeptides Glu or Asp-Lys-Tyr-Gly. Thus 7
out of 20 residues of each are in these homologous regions. Thus, we would
hypothesize that the peptides 51-70 and 81-100 may fold in such a way as to
form a homologous epitope containing either or both of these homologous
regions. Additional studies using variants of the 51-70 and 81-100 peptides may
better define the structural basis of this crossreactivity.
The findings presented here have shown that T cell clones specific for the
bacterially derived antigen Nase appear to be specific for one or another synthetic
peptide of the Nase sequence. Moreover, the identity of the peptide recognized
by a T cell clone correlated strongly with the MHC restriction specificity of that
T cell in the panel studied to date. These findings thus suggest a preferential
association between antigen fine specificity and la restriction in T cell responses,
and suggest that a limited T cell repertoire exists for immunogenic epitopes on
even phylogenetically and structurally distant protein molecules. The mechanism
underlying the selective association of antigenic epitopes with specific la mole-
cules is a subject of ongoing studies.
Summary
Previous studies (1) have indicated that the repertoire of murine T cells specific
for a potentially complex protein antigen is in fact specific for a limited number
of antigenic epitopes on that antigen in association with a given la molecule.
Since those studies generally analyzed responses to antigens that differ in only a
few amino acids from homologous murine molecules, it was possible that toler-
ance to self proteins was responsible for the limited T cell repertoire seen in
responses to closely related proteins. It was therefore of interest to determine
whether T cell recognition of a structurally and phylogenetically more distant
protein molecule would also show specificity for a limited number of immuno-
dominant peptides on that molecule. A series of experiments was designed to
study the antigen fine specificity and MHC restriction of T cell clones specific
for the bacterially derived antigen staphylococcal nuclease (Nase). T cell clones
generated in (H-2b x H-2a)F, (B6AF,) T cells were shown to be specific for Nase
and to be restricted by either Aa A16 or E. Es. The fine specificity of these clones
was then analyzed using cyanogen bromide and tryptic fragments and a series of
overlapping 20-amino-acid synthetic peptides corresponding to and spanning the
entire sequence of the Nase molecule. Two A. A'-restricted clones were highly
responsive to peptide 91-110, and not to other synthetic Nase peptides. In
contrast, seven E. E' restricted clones were consistently responsive to peptide
81-100 and not to 91-110 or to other Nase peptides. Certain of these E', E'0_
restricted T cells expressed an interesting crossreactivity, in that they responded
to peptide 51-70 as well as to 81-100, although the response to 51-70 was
characterized by a markedly shifted dose-response curve, indicating a reduced
efficiency of activation by this peptide. Analysis of the amino acid sequences of
these regions indicates that this unexpected crossreaction may have a structural
basis. A single Nase-specific T cell line generated from BALB/c T cells was, incontrast to any of the B6AF1 clones studied, responsive only to peptide 61-80
and not to other peptides, including 81-100 or 91-110 . Collectively, these
findings show that Nase-specific Tcells are responsive to discrete Nase peptides.
Moreover, the present findings suggest that in T cell recognition of a complex
and highly foreign protein antigen, a limited number of peptide epitopes are
preferentially recognized by T cells in association with a given la molecule.
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